10:08 AM
Feb 28, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Inflammatory disease

Cell culture and mouse studies identified two analogs of tozasertib, a tool compound pan-aurora kinase inhibitor, that could help treat systemic inflammatory response syndrome (SIRS). Chemical synthesis of tozasertib analogs and testing in a...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >